Autor: |
Evelijn Lourijsen, Mika J. Mäkelä, Ludger Klimek, Ralph Mösges, Wytske Fokkens, Sanna Toppila-Salmi, Valérie Hox, Kristian Aasbjerg, Thibaut Van Zele, Philippe Gevaert, Claus Bachert, Joaquim Mullol, Koen Boussery, Arnout Jordens, Sophie Scheire, Paloma Campo, P. V. Tomazic, Laura Pujols, Martin Wagemann, Ioana Agache, Isam Alobid, Job F M van Boven, Michael Rudenko, Carmen Rondon, Claire Hopkins, Glenis Scadding, Peter Hellings |
Přispěvatelé: |
UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service d'oto-rhino-laryngologie |
Rok vydání: |
2019 |
Předmět: |
|
Zdroj: |
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-27 (2020) Clinical and translational allergy, Vol. 10, no.1, p. 1 (2020) Clinical and Translational Allergy CLINICAL AND TRANSLATIONAL ALLERGY Clinical Translational Allergy, Vol. 10, no.1, p. 1 (2020) Recercat. Dipósit de la Recerca de Catalunya instname Dipòsit Digital de la UB Universidad de Barcelona |
ISSN: |
2045-7022 |
Popis: |
Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease. ispartof: CLINICAL AND TRANSLATIONAL ALLERGY vol:10 issue:1 ispartof: location:England status: published |
Databáze: |
OpenAIRE |
Externí odkaz: |
|